|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated financial statements of Uroplasty, Inc. and Subsidiaries
as of and for the year ended March 31, 2000 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> MAR-31-2000
<PERIOD-END> MAR-31-2000
<CASH> 1,553,093
<SECURITIES> 750,000
<RECEIVABLES> 954,525
<ALLOWANCES> 0
<INVENTORY> 735,630
<CURRENT-ASSETS> 4,393,531
<PP&E> 1,625,825
<DEPRECIATION> (528,707)
<TOTAL-ASSETS> 5,599,541
<CURRENT-LIABILITIES> 825,717
<BONDS> 528,808
0
0
<COMMON> 59,753
<OTHER-SE> 4,185,263
<TOTAL-LIABILITY-AND-EQUITY> 5,599,541
<SALES> 5,560,019
<TOTAL-REVENUES> 5,560,019
<CGS> 1,604,123
<TOTAL-COSTS> 1,604,123
<OTHER-EXPENSES> 5,301,815
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 28,021
<INCOME-PRETAX> (1,373,940)
<INCOME-TAX> (25,106)
<INCOME-CONTINUING> (1,348,834)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,348,834)
<EPS-BASIC> (0.23)
<EPS-DILUTED> (0.23)
</TABLE>
|
|